Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.47−0.01 (-2.16%)
Close on Nov 18, 2026Market cap $3.07MP/E –Yield –
Creative Medical Technology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Creative Medical Technology's pe ratio was 6.2× on Apr 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 6.2× | – |
See a number that looks wrong?